Cargando…

HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?

BACKGROUND: Since 1997 an effective prevention and treatment of infections with human immunodeficiency virus (HIV) have been available in the form of antiretroviral combination therapy. OBJECTIVE: What has been achieved during this time by transmission prophylaxis and treatment of HIV infections in...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Ulrich, Schulze Sturm, Ulf, Königs, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524331/
https://www.ncbi.nlm.nih.gov/pubmed/36213300
http://dx.doi.org/10.1007/s00112-022-01614-5
_version_ 1784800484858527744
author Baumann, Ulrich
Schulze Sturm, Ulf
Königs, Christoph
author_facet Baumann, Ulrich
Schulze Sturm, Ulf
Königs, Christoph
author_sort Baumann, Ulrich
collection PubMed
description BACKGROUND: Since 1997 an effective prevention and treatment of infections with human immunodeficiency virus (HIV) have been available in the form of antiretroviral combination therapy. OBJECTIVE: What has been achieved during this time by transmission prophylaxis and treatment of HIV infections in children in Germany? MATERIAL AND METHODS: Presentation of the development of transmission prophylaxis and the epidemiological surveys of the Robert Koch Institute, presentation of drug development and guidelines for antiretroviral therapy in children and adolescents and presentation of surveys of the German pediatric and adolescent HIV cohort (GEPIC). RESULTS: The introduction of HIV testing of pregnant women has made regular antiretroviral treatment of HIV positive pregnant women and the introduction of transmission-reducing measures possible. This has reduced the risk of vertical transmission from about 30% to < 1%. Currently, it is being investigated whether children exposed to HIV can be breastfed without risk. Antiretroviral therapy in children has decisively improved the survival rates and the physical and cognitive development of HIV positive children. New active substances have a more favorable side effect profile. In Germany, the World Health Organization (WHO) target of achieving complete suppression of the viral load in 90% of the children has been achieved. A delayed diagnosis in children and adolescents is still associated with severe infections. An HIV infection remains a disease with a stigma and is therefore usually kept secret from the children and their environment. CONCLUSION: With the transmission prophylaxis and therapy that are now available, it is possible to prevent transmission to a large extent and with a timely diagnosis to enable HIV positive children to lead a largely healthy life. The goal of children being able to know and name their disease without fear has still not been achieved.
format Online
Article
Text
id pubmed-9524331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-95243312022-10-03 HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht? Baumann, Ulrich Schulze Sturm, Ulf Königs, Christoph Monatsschr Kinderheilkd Leitthema BACKGROUND: Since 1997 an effective prevention and treatment of infections with human immunodeficiency virus (HIV) have been available in the form of antiretroviral combination therapy. OBJECTIVE: What has been achieved during this time by transmission prophylaxis and treatment of HIV infections in children in Germany? MATERIAL AND METHODS: Presentation of the development of transmission prophylaxis and the epidemiological surveys of the Robert Koch Institute, presentation of drug development and guidelines for antiretroviral therapy in children and adolescents and presentation of surveys of the German pediatric and adolescent HIV cohort (GEPIC). RESULTS: The introduction of HIV testing of pregnant women has made regular antiretroviral treatment of HIV positive pregnant women and the introduction of transmission-reducing measures possible. This has reduced the risk of vertical transmission from about 30% to < 1%. Currently, it is being investigated whether children exposed to HIV can be breastfed without risk. Antiretroviral therapy in children has decisively improved the survival rates and the physical and cognitive development of HIV positive children. New active substances have a more favorable side effect profile. In Germany, the World Health Organization (WHO) target of achieving complete suppression of the viral load in 90% of the children has been achieved. A delayed diagnosis in children and adolescents is still associated with severe infections. An HIV infection remains a disease with a stigma and is therefore usually kept secret from the children and their environment. CONCLUSION: With the transmission prophylaxis and therapy that are now available, it is possible to prevent transmission to a large extent and with a timely diagnosis to enable HIV positive children to lead a largely healthy life. The goal of children being able to know and name their disease without fear has still not been achieved. Springer Medizin 2022-09-30 2022 /pmc/articles/PMC9524331/ /pubmed/36213300 http://dx.doi.org/10.1007/s00112-022-01614-5 Text en © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Baumann, Ulrich
Schulze Sturm, Ulf
Königs, Christoph
HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title_full HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title_fullStr HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title_full_unstemmed HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title_short HIV-Infektion und -Exposition bei Kindern und Jugendlichen: 25 Jahre antiretrovirale Prophylaxe und Therapie: Was ist erreicht?
title_sort hiv-infektion und -exposition bei kindern und jugendlichen: 25 jahre antiretrovirale prophylaxe und therapie: was ist erreicht?
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524331/
https://www.ncbi.nlm.nih.gov/pubmed/36213300
http://dx.doi.org/10.1007/s00112-022-01614-5
work_keys_str_mv AT baumannulrich hivinfektionundexpositionbeikindernundjugendlichen25jahreantiretroviraleprophylaxeundtherapiewasisterreicht
AT schulzesturmulf hivinfektionundexpositionbeikindernundjugendlichen25jahreantiretroviraleprophylaxeundtherapiewasisterreicht
AT konigschristoph hivinfektionundexpositionbeikindernundjugendlichen25jahreantiretroviraleprophylaxeundtherapiewasisterreicht